Table 1.
General clinical data for all enrolled DKD patients.
| Parameter | Values |
|---|---|
| Patients (n) | 79 |
| Gender (male/female) | 64/15 |
| Age (years) | 50.91 ± 11.34 |
| Duration of diabetes (years) | 11.0 ± 6.23 |
| Glycosylated hemoglobin (%) | 7.69 ± 1.76 |
| Serum albumin (g/L) | 31.44 ± 6.93 |
| TG (mmol/L) | 1.54 (1.07,2.3) |
| TC (mmol/L) | 5.37 ± 1.81 |
| LDL-C | 3.47 ± 1.29 |
| HDL-C | 1.05 (0.85,1.36) |
| Scr (umol/L) | 112.6 (90.8,175.4) |
| Urinary protein (g/d) | 2.93 (1.84,6.96) |
| eGFR (ml/min/1.73 m2) | 61 (37,82) |
| Glomerular class | |
| I | 0 (0) |
| IIa | 4 (5.1%) |
| IIb | 17 (21.5%) |
| III | 41 (51.9%) |
| IV | 17 (21.5%) |
| Progression to ESRD (%) | 32 (40.5%) |
| Progression to doubling of creatinine (%) | 8 (10.1%) |
DKD, diabetic kidney disease; eGFR, estimated glomerular filtration rate; Scr, serum creatine; HDL-C, high-density lipoprotein cholesterol; LDL-C, low-density lipoprotein cholesterin; TG, triglyceride; TC, total cholesterol; ESRD, end stage renal disease.
Data were presented as the mean ± standard or as medians (IQR). A two-tailed p < 0.05 was considered statistically significant.